According to our latest study on “Non-Alcoholic Steatohepatitis (NASH) Market Forecast to 2028 – COVID-19 Impact and Global Analysis – Product, Application, and Sales Channel," the market is expected to grow from US$ 1,631.92 million in 2021 to US$ 24,266.81 million by 2028; it is estimated to grow at a CAGR of 47.1% from 2021 to 2028.
The report features the...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian